Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NeoVista Inc.

www.neovistainc.com

Latest From NeoVista Inc.

Recent Financings of Private Companies, July-August 2012

START-UP’s monthly comprehensive review of emerging life science companies that have received venture funding during the month, including companies within the in vitro diagnostics, pharmaceuticals, research/analytical equipment & supplies, and medical device sectors.

BioPharmaceutical Medical Device

Medical Device Deals Update, June/July 2012

A roundup of recent medtech mergers & acquisitions, strategic alliances, and financings.

Medical Device

Retinal Disease: Much Progress, Some Pain

On many fronts, 2011 was an event-filled year for the retinal disease market, beginning with the publication of the CATT trial comparing off-label intravitreal Avastin versus Lucentis for the treatment of AMD, and ending with several important milestones for device manufacturers operating in this space. But while the retinal device field is making progress in many areas, companies continue to struggle to meet shifting FDA approval requirements.

BioPharmaceutical Medical Device

Device Companies Look West, East, Anyplace But US

With clear regulatory approval paths in Europe and growing markets in Asia and other developing markets, device executives and investors see international markets as increasingly attractive alternatives for clinical validation, revenue, and regulatory approval.
Medical Device Asia Pacific
See All

Company Information

  • Industry
  • Medical Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
  • Therapeutic Areas
  • Ophthalmic
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • NeoVista Inc.
  • Senior Management
  • John N Hendrick, Pres. & CEO
    Tony Moses, VP, Sales & Mktg.
    David Gyorke, VP, R&D
    Tim Dumke, VP, Fin.
  • Contact Info
  • NeoVista Inc.
    Phone: (510) 933-7600
    38875 Cherry St.
    Newark, CA 94560
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register